EGFR and Alzheimer disease: A potential indication for their efficacy in AD derives from evidence for a putative role of the EGFR pathway in suppressing autophagy and the demonstration that its inhibition decreased amyloid-β secretion in vitro and in vivo and improved cognitive functions in AD models58,59.